Aurora Cannabis Inc. (NASDAQ:ACB) Short Interest Update

Aurora Cannabis Inc. (NASDAQ:ACBGet Free Report) was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 3,820,000 shares, a growth of 14.7% from the February 29th total of 3,330,000 shares. Currently, 24.5% of the company’s stock are short sold. Based on an average trading volume of 1,500,000 shares, the days-to-cover ratio is currently 2.5 days.

Aurora Cannabis Price Performance

NASDAQ ACB opened at $4.31 on Tuesday. The business’s fifty day moving average price is $3.70 and its 200-day moving average price is $4.61. The stock has a market capitalization of $235.06 million, a price-to-earnings ratio of -1.49 and a beta of 2.32. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.79 and a quick ratio of 2.45. Aurora Cannabis has a 1-year low of $2.84 and a 1-year high of $11.50.

Aurora Cannabis (NASDAQ:ACBGet Free Report) last released its quarterly earnings results on Thursday, February 8th. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.10). The firm had revenue of $53.34 million for the quarter, compared to the consensus estimate of $45.94 million. Aurora Cannabis had a negative net margin of 48.82% and a negative return on equity of 23.27%. On average, equities analysts predict that Aurora Cannabis will post -0.85 earnings per share for the current year.

Institutional Investors Weigh In On Aurora Cannabis

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. increased its stake in shares of Aurora Cannabis by 69.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 283,867 shares of the company’s stock worth $135,000 after purchasing an additional 116,584 shares in the last quarter. TD Asset Management Inc purchased a new stake in shares of Aurora Cannabis in the 4th quarter worth $218,000. Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Aurora Cannabis in the 4th quarter worth $42,000. Mackenzie Financial Corp purchased a new stake in shares of Aurora Cannabis in the 4th quarter worth $98,000. Finally, Deutsche Bank AG purchased a new stake in shares of Aurora Cannabis in the 3rd quarter worth $32,000. 47.63% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Canaccord Genuity Group raised Aurora Cannabis from a “hold” rating to a “buy” rating in a research report on Friday, February 9th.

Check Out Our Latest Research Report on ACB

Aurora Cannabis Company Profile

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

Further Reading

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.